SUMMARY Twenty-eight patients with epilepsy were seen on two occasions at an interval of three months. On one session anticonvulsant serum levels were high and on the other session the serum levels were lower. On each of the two sessions patients performed a series of psychological tests and had a blood sample taken for the analysis of anticonvulsant serum concentrations. Seizure frequency in the previous three months was documented and several patients had an EEG recording made. Deficits in psychological test performance were found at high serum concentrations. Furthermore, lower serum level concentrations did not appear to be accompanied by worsened seizure control.
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Anticonvulsant serum levels are thought to provide a better indicator of clinical response and the incidence of neurotoxic side effects in patients with epilepsy than doses of drugs. ' Therapeutic ranges have been established for several anticonvulsants within which maximum seizure control may be expected with minimum occurrence of side effects, such as nystagmus, ataxia, diplopia and mental confusion.2 However, it is unclear whether serum level monitoring may also prove useful for avoiding detrimental drug-induced changes in cognitive functioning which have been reported.3 In the assessment of the effects of these drugs on cognition only a few investigators have included measurements of anticonvulsant serum concentrations and several have reported impairments in association with high but not always toxic levels. [4] [5] [6] [7] [8] [9] The majority of studies have either compared the psychological test performance of two groups of patients, divided about some arbitrary cut-off value into high and low serum groups,56 or To explore further the relationship between anticonvulsant serum levels and cognitive functioning, in particular whether adverse effects do occur at therapeutic concentrations, we have undertaken a study involving patients with epilepsy. To avoid the problems of interpretation of earlier investigations, a longitudinal design was adopted in which patiente performance on a series of specially designed psychological tests was measured at high and low 228 anticonvulsant serum concentrations. The findings of this study are reported in this paper.
Method
Patients Sixteen male and twelve female patients with a diagnosis of epilepsy participated in the study. No patient had undergone surgery in the past five years, had any signs of a progressive brain lesion or was prescribed any regular medication other than anticonvulsants. The mean age of the sample was 23-3 years (range and their mean IQ was 99 (range 64-130). Three patients were still attefiding school or college and the remaining 27 had completed a mean of 1 1-4 years' education (range 9-16). The mean age of onset of epilepsy was 8-4 years (range 1-21) with a mean duration of 14-8 years (range 4-45). Seizure type was primary generalised in six cases, secondary generalised in nineteen, partial in two and mixed in one. Sixteen patients were seen while attending a short-stay unit at a special centre for epilepsy and the remaining twelve were seen as outpatients at a neurological hospital. Patients were prescribed the same medication throughout the investigation; eight were taking phenytoin, five carbamazepine, five sodium volproate, three phenytoin and carbamazepine, two sodium valproate and carbamazepine, two primidone and carbamazepine, one primidone and phenytoin, one phenytoin and phenobarbitone and one primidone.
Design
All patients formed part of a larger investigation (Thompson- The psychological tests employed are outlined briefly having been described in detail elsewhere. '4 's 1 Memory Twenty pictures and twenty words were displayed as slides at the beginning of each session. One minute and again one hour following the presentation of the last stimuli in each set, recall was tested. A yes/no recognition test was then administered in which the twenty original slides were presented in a random order with 20 new slides. A different set of stimulus items and recognition distractors was used on the two testing sessions.
Thompson, Trimble 2 Concentration (i) Stroop Test. The version used consisted of three cards. The task was to read the colour words (red, blue, green) on the first card (I) and to name the coloured rectangles (red, blue, green) on the second card (II) as quickly as possible. On the third card the colour words (red, blue, green) were printed in various colours (red, blue, green) never congruent with the word, and subjects were required to name the colour the words were written in as quickly as possible. The difference in the time taken to complete cards II and III and the number of errors made on card III were used as the measures of performance.
(ii) Visual scanning. The time taken to cancel a target digit from a page of random numbers was recorded in two conditions: (a) alone, and (b) in the presence of an auditory distracting task. 3 Mental speed (i) Perceptual speed. The minimum exposure duration at which subjects could recognise pictures of objects and words in a masking paradigm was used to assess the speed of perceptual registration.
(ii) Decision Table 4 Means and ranges ofthe anticonvulsant serum levels (pnolll) ofthe non-intoxicated patients in the high and low '6 It is important to note from our investigations that deficits in performance in association with high serum levels were generally not noted until the psychological test became more exacting, and it seems likely that such impairments would be overlooked in a standard out-patient interview, even using ordinary clinical assessments of the mental state. In order to adequately assess the influence of anticonvulsants on cognitive functioning in patients with epilepsy, future research should be carried out
